Gun­ning for Bio­gen’s multi­bil­lion dol­lar mar­ket, Eli Lil­ly cuts up an­oth­er batch of Alzheimer’s da­ta

Eli Lil­ly ex­ec­u­tives have their eyes set on Bio­gen’s multi­bil­lion-dol­lar Alzheimer’s mar­ket.

On Thurs­day, the In­di­anapo­lis phar­ma tried to bol­ster its case to win ac­cel­er­at­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER